Author | Thomas Cluzeau, MD, PhD | OncLive

Author | Thomas Cluzeau, MD, PhD

Articles

Dr. Cluzeau on the Efficacy of APR-246/Azacitidine in TP53-Mutated MDS and AML

June 13, 2020

Video

Thomas Cluzeau, MD, PhD, discusses the response rates of a phase 2 study with APR-246 and azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia.

x